Storico di ricavi, utili e flussi di cassa dai bilanci ufficiali.
Kimberly-Clark Corporation, insieme alle sue controllate, produce e commercializza prodotti per la cura personale negli Stati Uniti. Opera in due segmenti, Nord America e International Personal Care.
Tradotto automaticamente
Vedi grafici interattivi e bilanci completi → Modello di valutazione (DCF) →
| Conto economico | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Entrate totali | $16.6B | $17.2B | $20.1B | $20.4B | $20.2B | $19.4B | $19.1B | $18.4B | $18.5B | $18.3B | $18.2B | $18.6B | $19.7B | $21.2B | $21.1B | $20.8B | $19.7B | $19.1B | $19.4B | $18.3B | $16.7B |
| Utile lordo | $6.1B | $6.1B | $7.2B | $7.0B | $6.2B | $6.0B | $6.8B | $6.0B | $5.6B | $6.6B | $6.7B | $6.6B | $6.7B | $7.2B | $6.7B | $6.2B | $6.5B | $6.4B | $5.9B | $5.7B | $5.4B |
| Margine lordo% | 36.7% | 35.6% | 35.8% | 34.4% | 30.8% | 30.8% | 35.6% | 32.7% | 30.3% | 36.1% | 36.8% | 35.6% | 33.9% | 34.2% | 32.0% | 29.5% | 33.2% | 33.6% | 30.2% | 31.2% | 32.4% |
| Risultato Operativo (EBIT) | $2.1B | $2.5B | $3.2B | $2.3B | $2.7B | $2.6B | $3.2B | $3.0B | $2.2B | $3.4B | $3.4B | $1.6B | $2.5B | $3.2B | $2.7B | $2.9B | $2.9B | $3.1B | $2.6B | $2.7B | $2.6B |
| Margine operativo % | 12.4% | 14.5% | 16.0% | 11.5% | 13.3% | 13.2% | 17.0% | 16.2% | 12.1% | 18.4% | 18.6% | 8.7% | 12.8% | 15.2% | 12.8% | 13.7% | 14.8% | 16.2% | 13.6% | 14.9% | 15.6% |
| Reddito netto | $2.0B | $2.0B | $2.5B | $1.8B | $1.9B | $1.8B | $2.4B | $2.2B | $1.4B | $2.3B | $2.2B | $1.0B | $1.5B | $2.1B | $1.8B | $1.6B | $1.8B | $1.9B | $1.7B | $1.8B | $1.5B |
| Margine netto% | 11.8% | 11.7% | 12.7% | 8.6% | 9.6% | 9.3% | 12.3% | 11.7% | 7.6% | 12.5% | 11.9% | 5.5% | 7.7% | 10.1% | 8.3% | 7.6% | 9.3% | 9.9% | 8.7% | 10.0% | 8.9% |
| EBITDA | $3.1B | $3.1B | $4.0B | $2.3B | $3.4B | $3.2B | $4.0B | $3.8B | $3.0B | $4.0B | $4.0B | $2.4B | $3.4B | $4.1B | $3.6B | $3.6B | $3.6B | $3.6B | $3.3B | $3.4B | $3.0B |
| Utile per azione (EPS) | $5.87 | $6.07 | $7.55 | $5.20 | $5.72 | $5.35 | $6.87 | $6.24 | $4.03 | $6.40 | $5.99 | $2.77 | $4.04 | $5.53 | $4.42 | $3.99 | $4.45 | $4.52 | $4.04 | $4.09 | $3.25 |
| Azioni in circolazione (M) | 333M | 333M | 337M | 339M | 338M | 339M | 342M | 346M | 350M | 356M | 362M | 366M | 377M | 387M | 396M | 399M | 414M | 417M | 419M | 446M | 461M |
Fonte: bilanci pubblici della società (SEC). Verificare su SEC EDGAR prima di fare affidamento su qualsiasi cifra.
Stati patrimoniali, flussi di cassa, dati trimestrali e indici completi nel visualizzatore interattivo di KMB. /companies/us/KMB
Le informazioni di questo sito sono solo a scopo educativo e informativo; non costituiscono consulenza finanziaria. Non vengono pubblicati prezzi obiettivo né raccomandazioni.
About TickerBase · Data methodology & sources · Privacy · Terms